Microvascular Reactivity.

Sponsor
Yale University (Other)
Overall Status
Completed
CT.gov ID
NCT00259701
Collaborator
(none)
20
1
3
6.6

Study Details

Study Description

Brief Summary

This study attempts to test capillary responses to various challenges without the need for iontophoresis (electrical current).

Condition or Disease Intervention/Treatment Phase
  • Device: Laser Doppler Flowmetry with topical acetylcholine and nitroglycerin

Detailed Description

Studies of microvascular responsiveness often employ iontophoresis to fascilitate drug absorption. Iontophoresis is a confounding stimulus in such studies, and we are attempting to create tests of the microvasculature that do not require iontophoretic drug delivery.

Study Design

Study Type:
Observational
Observational Model:
Defined Population
Time Perspective:
Other
Official Title:
Transdermal Application of Acetylcholine and Nitroglycerin Without Iontophoresis.
Study Start Date :
Jun 1, 2005
Study Completion Date :
Sep 1, 2005

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    Inclusion Criteria: diabetic. -

    Exclusion Criteria: not on nitrates or mydriatic eye drops within 48 hours.

    -

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Yale School of Medicine New HAven Connecticut United States 06510

    Sponsors and Collaborators

    • Yale University

    Investigators

    • Principal Investigator: David G Silverman, Yale School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00259701
    Other Study ID Numbers:
    • HIC-12397-1
    First Posted:
    Nov 29, 2005
    Last Update Posted:
    Oct 6, 2006
    Last Verified:
    Nov 1, 2005

    Study Results

    No Results Posted as of Oct 6, 2006